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Organization,  2003).  Efforts  to  limit 
  pneumococcal  disease  have  focused  pri-
marily on antibiotic intervention and vac-
cination. However, after initial, and often 
dramatic, successes the effectiveness of these 
measures has consistently been overcome 
by  the  extremely  adaptable  and  resilient 
pneumococcus. S. pneumoniae is naturally 
competent and readily incorporates DNA 
fragments  derived  from  pneumococcal 
and  non-pneumococcal  bacterial  species 
into  its  genome  by  homologous  recom-
bination.  High  levels  of  recombination 
have resulted in extreme diversity within 
pneumococcal  populations  from  which 
variant genotypes can rapidly emerge in 
the presence of changing selective pressures. 
The primary pressures outside of natural 
immunity  are  antibiotics  and  pneumo-
coccal conjugate polysaccharide vaccines. 
Resistant  and  multidrug  resistant  pneu-
mococci have emerged since the late 1960s 
and now severely limit treatment options 
for pneumococcal diseases (Reinert, 2009). 
The incidences of invasive pneumococcal 
disease (IPD) and antibiotic resistant pneu-
mococci decreased dramatically following 
the introduction of the heptavalent conju-
gate vaccine PCV7 in 2000 (Dagan, 2009). 
However, the incidence of IPD and resist-
ance is again rising due to the emergence of 
multidrug resistant, non-vaccine “replace-
ment” serotypes.
Croucher et al. (2011) documented the 
“escape” of the PMEN1 clone from PCV7 
by  indentifying  several  independent 
horizontal transfer events that resulted 
in serotype switching of PMEN1 strains 
from vaccine serotype 23F to non-vaccine 
serotypes.  This  suggested  strong  selec-
tive pressures for capsule switch variants 
exerted by the PCV7-immunized human 
immune system. Evidence for the selective 
pressures exerted by antibiotics was also 
reported. Analysis of integrative and con-
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The  landmark  paper  recently  published 
by Croucher et al. (2011) reports the draft 
genome  sequencing  of  240  Streptococcus 
pneumoniae isolates and demonstrates the 
power of comparative genomics in the epi-
demiological and phylogenetic analysis of 
bacterial pathogens.
Until  recently,  the  focus  of  bacte-
rial genome projects has been individual 
strains or small numbers of clinical isolates. 
However, with the advent of next genera-
tion sequencing platforms such as Roche 
454 and Illumina, bacterial genomes can 
be  inexpensively  and  rapidly  sequenced. 
The first large-scale genomic sequencing 
project to utilize these technologies for a 
similar purpose (also by the Bentley group) 
analyzed  63  clonally  related  methicillin-
resistant  Staphylococcus  aureus  isolates 
(Harris et al., 2010). Croucher et al. (2011) 
analyzed  temporally  and  geographically 
diverse isolates of a single S. pneumoniae 
lineage, the multidrug resistant Spain 23F 
ST81 (PMEN1) pandemic clone, to provide 
insights  into  the  microevolution  of  this 
important pathogen.
Streptococcus  pneumoniae  is  a  major 
worldwide  public  health  concern.  It  is 
responsible  for  an  estimated  1.6  million 
deaths each year, half of which are chil-
dren under the age of five (World Health 
jugative elements revealed rapid degener-
ation of such elements but with consistent 
retention of determinants of resistance to 
antibiotics commonly used in treatment 
of  upper  respiratory  infections  (e.g., 
b-lactams  and  macrolides).  It  should 
be expected that the pneumococcus will 
adapt  quickly  to  new  antibiotic  pres-
sures and vaccines such as the 13-valent 
PCV vaccine (PCV13) introduced in the 
United States early 2010. This emphasizes 
the importance of surveillance and epide-
miology to track the emergence of new 
clones and variations.
In  addition  to  overcoming  clinical 
interventions, the plasticity of the pneu-
mococcal genome has confounded epide-
miological analyses. Multilocus sequence 
typing (MLST) is currently the preferred 
method  for  comparing  relatedness  of 
isolates within a given bacterial species, 
and  relies  on  sequence  comparison  of 
seven highly conserved alleles. However, 
the high rate of recombination in pneu-
mococci  greatly  reduces  the  resolution 
of  MLST-derived  pneumococcal  phyl-
ogenies due to horizontal acquisition of 
single nucleotide polymorphisms (SNPs) 
by recombination events involving MLST 
alleles.  Croucher  et  al.  (2011)  avoided 
this  problem  by  removing  horizontally 
inherited  sequences  from  the  phyloge-
netic  analyses.  Recombination  events 
were  identified  by  comparison  of  each 
genome to a Spain 23F ST81 reference 
genome (ATCC 700669; Croucher et al., 
2009). The phylogeny constructed using 
only vertically inherited SNPs proved to 
be  a  superior  estimation  of  the  evolu-
tion of the clone based on the correla-
tion between the distance from the root 
of the tree and the date of isolation of 
each strain. By comparing the more accu-
rate phylogeny to the dates and locations 
of  isolation,  the  authors  were  able  to 
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invasive disease as well as inter- and intra-
species horizontal gene transfer in S. pneu-
moniae. Similarly, study of the evolution of 
pneumococcal isolates within a single host 
will help define risks of acquired antibi-
otic resistance in the presence of antibiotic 
therapy and other interventions.
Current  and  next  generation  tech-
nologies will be invaluable for epidemi-
ologists  and  microbiologists  studying 
non-  pneumococcal pathogens, and com-
mensals. Large-scale genomic analyses may 
lead to identification of novel therapeutic 
agents and new vaccine targets. Croucher 
et al. (2011) are one of the first groups to 
realize the full potential of the develop-
ments  in  DNA  sequencing  technologies 
that powered these large scale comparative 
genomic projects. This report signals the 
beginning of an era of discovery that will 
lead to comprehensive understanding of 
bacterial evolution, will revolutionize epi-
demiology, and allow the development of 
more effective and longer lasting strategies 
to treat infectious diseases.
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  pinpoint  the  likely  origins  of  different 
clades and to discern information about 
the geographic spread of the clone.
Future studies utilizing large-scale genomic 
comparison in S. pneumoniae will likely focus 
on the influence of antibiotic and vaccine 
pressures  and  on  the  evolution  of  pneu-
mococcal  populations.  Whereas  Croucher 
et al. (2011) utilized “deep” sequencing into 
a single lineage, “wide” genomic analysis of 
isolates that encompass entire pneumococ-
cal populations will provide insights into the 
evolution and interactions of multiple line-
ages. In addition, it will elucidate the effects 
of localized factors such as host population 
genetic composition and confounding health 
and socioeconomic factors. In particular, it 
will clarify the effects of vaccine and antibi-
otic pressures on the population and identify 
candidate lineages for deep sequencing.
Sequencing  technologies  have  also 
enabled analysis of entire bacterial popu-
lations  in  individual  niches,  such  as  the 
Human Microbiome Project (HMP). The 
HMP attempts to elucidate the composition 
and role of the microbiota that inhabit the 
human body. Such studies in the nasophar-
ynx  will  provide  a  better  understanding 
of  the  role  of  pneumococcal  carriage  in 
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